683 Capital Management »

Oramed Pharm shares owned by 683 Capital Management

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $247k 21k 12.03

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Oramed Pharm

BML Capital Management
Aquamarine Financial
Murchinson
Boothbay Fund Management
Rathbones Brothers
Renaissance Technologies
Dimensional Fund Advisors
Wells Fargo & Company
Citadel Advisors
BlackRock
Jane Street
Rbf Capital
Susquehanna International
Squarepoint Ops
Connor, Clark & Lunn Investment Management

View all funds holding Oramed Pharm